Selected article for: "active treatment and acute ards respiratory distress syndrome"
Author: Zahar, Jean-Ralph; Azoulay, Elie; Klement, Elise; De Lassence, Arnaud; Lucet, Jean-Christophe; Regnier, Bernard; Schlemmer, Benoît; Bedos, Jean-Pierre
Title: Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure
  • Cord-id: trghbx79
  • Document date: 2014_3_18
    • ID: trghbx79
    Snippet: Objectives: To clarify the patterns of pulmonary tuberculosis (TB) that should result in a high index of suspicion, to increase the chances of early therapy and to identify predictors of 30-day mortality. Patients and methods: Retrospective, 7-year study in two medical intensive care units (ICUs). All patients admitted with pulmonary TB were enrolled. Clinical and laboratory data at admission and events within 48 h of admission were collected. Predictors of 30-day mortality were identified by un
    Document: Objectives: To clarify the patterns of pulmonary tuberculosis (TB) that should result in a high index of suspicion, to increase the chances of early therapy and to identify predictors of 30-day mortality. Patients and methods: Retrospective, 7-year study in two medical intensive care units (ICUs). All patients admitted with pulmonary TB were enrolled. Clinical and laboratory data at admission and events within 48 h of admission were collected. Predictors of 30-day mortality were identified by univariate and multivariate analysis. Results: The study included 99 patients with a median age of 41 years. Immunodeficiency was present in 60 patients, including 38 with AIDS. Fifty-nine patients had pulmonary TB alone, 22 also had extrapulmonary TB and 18 had miliary. All 99 patients were admitted for acute respiratory failure, some also with shock (20), neurologic disorders (18) or acute renal failure (10). Mechanical ventilation was needed in 50 patients; 22 patients met criteria for acute respiratory distress syndrome (ARDS). The 30-day mortality rate was 26.2%. Four factors independently predicted mortality: a time from symptom onset to treatment of more than 1 month (OR, 3.49; CI, 1.20–10.20), the number of organ failures (OR, 3.15; CI, 1.76–5.76), a serum albumin level above 20 g/l (OR, 3.96; CI, 1.04–15.10), and a larger number of lobes involved on chest radiograph (OR, 1.83; CI, 1.12–2.98). Conclusion: Delayed clinical suspicion and treatment of active pulmonary TB with respiratory failure may contribute to the persistently high mortality rates in ICU patients with these diseases.

    Search related documents:
    Co phrase search for related documents
    • abstract objective and acute ards respiratory distress syndrome: 1
    • abstract objective and admission reason: 1
    • abstract objective and liver function: 1, 2
    • acid fast bacilli and active pulmonary tb: 1
    • acid fast bacilli and acute ards respiratory distress syndrome: 1
    • acid fast bacilli and acute respiratory failure: 1
    • acid fast bacilli and liver function: 1, 2
    • active infection and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • active infection and acute respiratory failure: 1, 2, 3, 4, 5
    • active infection and admission reason: 1
    • active infection and liver function: 1, 2, 3, 4
    • active pulmonary tuberculosis and acute ards respiratory distress syndrome: 1
    • active pulmonary tuberculosis and acute respiratory failure: 1, 2
    • acute ards respiratory distress syndrome and admission parameter: 1
    • acute ards respiratory distress syndrome and admission reason: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and admission serum albumin: 1
    • acute respiratory failure and admission reason: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory failure and admission saps ii score: 1
    • acute respiratory failure and admission serum albumin: 1, 2